Back to 
WELLINGTON MANAGEMENT GROUP LLP
WELLINGTON MANAGEMENT GROUP LLP
SGMOQShowing 0 of 3 quarters
Position history for WELLINGTON MANAGEMENT GROUP LLP's holdings in SANGAMO THERAPEUTICS, INC
No. Wellington Management Group exited its SGMOQ (Sangamo Therapeutics) position in Q1 2020. Its Q4 2019 13F listed 7,746,382 shares worth $64.8M. Wellington Management Group already held SGMOQ in its Q3 2019 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of SGMOQ: WASATCH ADVISORS LP, STATE STREET CORP